z-logo
open-access-imgOpen Access
Spotlight on Impactful Research: Low‐Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate‐Risk Liver Transplantation Recipients
Author(s) -
Loy Veronica
Publication year - 2021
Publication title -
clinical liver disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 14
ISSN - 2046-2484
DOI - 10.1002/cld.962
Subject(s) - valganciclovir , ganciclovir , cytomegalovirus , medicine , liver transplantation , transplantation , gastroenterology , serology , immunology , human cytomegalovirus , herpesviridae , virus , viral disease , antibody
Watch a video presentation of this article

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom